Peer Review Policy

The International Journal of Medical Science and Clinical Invention (IJMSCI) uses a double-blind peer review process to ensure the quality of the articles published in the journal. The peer review process is designed to provide a fair, impartial, and rigorous evaluation of the manuscript, and to ensure that the scientific record remains accurate and reliable.

The Peer Review Process:

• Upon receipt of a manuscript, the Editor-in-Chief will conduct a preliminary evaluation to determine if the manuscript is suitable for publication in IJMSCI.
• If the manuscript is deemed suitable, it will be sent to at least two independent experts in the field for review.
• The reviewers will evaluate the manuscript anonymously and provide detailed and constructive feedback on its strengths and weaknesses.
• Based on the reviewer feedback, the Editor-in-Chief will make a decision on the suitability of the manuscript for publication. This decision may be to accept the manuscript for publication, reject the manuscript, or request revisions with specific suggestions for improvement.
• If revisions are required, the authors will be given the opportunity to revise their manuscript and resubmit it for review.
• The final decision on publication will be made by the Editor-in-Chief, taking into account the reviewer feedback and any revisions made by the authors.

Benefits of Peer Review:

• The peer review process helps to ensure the quality of the articles published in IJMSCI by providing a rigorous evaluation of the manuscript.
• The peer review process helps to identify and correct any weaknesses or inaccuracies in the manuscript, improving its overall quality and readability.
• The peer review process provides authors with valuable feedback on their work, helping them to improve their research and writing skills.

We hope that this policy provides you with a clear understanding of the peer review process at IJMSCI and how it benefits the authors, reviewers, and readers of the journal.